Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.490
+0.020 (1.36%)
Sep 28, 2026, 3:03 PM EDT - Market open
Cellectis Market Cap
Cellectis has a market cap or net worth of $103.39 million as of September 28, 2026. Its market cap has decreased by -58.81% in one year.
Market Cap
103.39M
Enterprise Value
17.27M
1-Year Change
-58.81%
Ranking
Category
Stock Price
$1.49
ChartMarket Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $103.39M, a decrease of -92.31%. That is a compound annual growth rate of -19.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 106.90M | -69.47% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 109.72M |
| Black Diamond Therapeutics | 108.01M |
| PolyPid | 106.03M |
| Equillium | 105.89M |
| Rani Therapeutics Holdings | 105.83M |
| Seer, Inc. | 105.76M |
| Polaryx Therapeutics | 104.18M |
| Tenax Therapeutics | 103.68M |